| 10/28/2021 |
Research |
Cash or cash equivalent |
|
$2645.00 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
834357421 |
|
| 03/01/2021 |
Research |
Cash or cash equivalent |
|
$2935.65 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
834357149 |
|
| 01/07/2021 |
Research |
Cash or cash equivalent |
|
$77.39 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
834356999 |
|
| 01/18/2021 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
834356995 |
|
| 10/16/2021 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$22.08 |
Details |
| Payment from |
Allergan, Inc. |
| Payment Record ID |
792696701 |
|
| 10/22/2020 |
Research |
Cash or cash equivalent |
Drug |
$50.00 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733484343 |
|
| 08/20/2020 |
Research |
Cash or cash equivalent |
Drug |
$640.00 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733484245 |
|
| 06/22/2020 |
Research |
Cash or cash equivalent |
Drug |
$75.00 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733484065 |
|
| 05/14/2020 |
Research |
Cash or cash equivalent |
Drug |
$200.00 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733484011 |
|
| 05/14/2020 |
Research |
Cash or cash equivalent |
Drug |
$1962.47 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733484009 |
|
| 04/20/2020 |
Research |
Cash or cash equivalent |
Drug |
$6989.50 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733483877 |
|
| 04/13/2020 |
Research |
Cash or cash equivalent |
Drug |
$50.00 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733483875 |
|
| 03/10/2020 |
Research |
Cash or cash equivalent |
Drug |
$13.16 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733483775 |
|
| 03/10/2020 |
Research |
Cash or cash equivalent |
Drug |
$8.97 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733483773 |
|
| 03/10/2020 |
Research |
Cash or cash equivalent |
Drug |
$46.87 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733483771 |
|
| 03/16/2020 |
Research |
Cash or cash equivalent |
Drug |
$640.00 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733483757 |
|
| 03/16/2020 |
Research |
Cash or cash equivalent |
Drug |
$100.00 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733483755 |
|
| 02/24/2020 |
Research |
Cash or cash equivalent |
Drug |
$150.00 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733483489 |
|
| 02/24/2020 |
Research |
Cash or cash equivalent |
Drug |
$150.00 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733483487 |
|
| 01/17/2020 |
Research |
Cash or cash equivalent |
Drug |
$4.83 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733483253 |
|
| 01/17/2020 |
Research |
Cash or cash equivalent |
Drug |
$13.00 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733483251 |
|
| 01/17/2020 |
Research |
Cash or cash equivalent |
Drug |
$9.64 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733483249 |
|
| 01/17/2020 |
Research |
Cash or cash equivalent |
Drug |
$93.22 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733483247 |
|
| 01/10/2020 |
Research |
Cash or cash equivalent |
Drug |
$4.83 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733483245 |
|
| 01/21/2020 |
Research |
Cash or cash equivalent |
Drug |
$12454.59 |
Details |
| Payment from |
Ichnos Sciences Inc. |
| Paymment Research Study |
GBR830-204 |
| Payment Record ID |
733483221 |
|
| 11/05/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.17 |
Details |
| Payment from |
Mayne Pharma Inc. |
| Payment Record ID |
705487815 |
|
| 11/20/2019 |
Research |
Cash or cash equivalent |
|
$3.93 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689435193 |
|
| 11/20/2019 |
Research |
Cash or cash equivalent |
|
$10.55 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689435191 |
|
| 11/20/2019 |
Research |
Cash or cash equivalent |
|
$47.15 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689435189 |
|
| 11/20/2019 |
Research |
Cash or cash equivalent |
|
$4.52 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689435187 |
|
| 11/19/2019 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689435165 |
|
| 11/12/2019 |
Research |
Cash or cash equivalent |
|
$150.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689435163 |
|
| 10/03/2019 |
Research |
Cash or cash equivalent |
|
$108.08 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689435001 |
|
| 10/03/2019 |
Research |
Cash or cash equivalent |
|
$30.15 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434999 |
|
| 10/03/2019 |
Research |
Cash or cash equivalent |
|
$262.29 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434997 |
|
| 10/03/2019 |
Research |
Cash or cash equivalent |
|
$9.04 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434995 |
|
| 10/01/2019 |
Research |
Cash or cash equivalent |
|
$1000.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434989 |
|
| 10/01/2019 |
Research |
Cash or cash equivalent |
|
$5350.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434987 |
|
| 10/29/2019 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434985 |
|
| 10/15/2019 |
Research |
Cash or cash equivalent |
|
$361.58 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434983 |
|
| 10/22/2019 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434981 |
|
| 10/22/2019 |
Research |
Cash or cash equivalent |
|
$1000.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434979 |
|
| 10/15/2019 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434977 |
|
| 10/15/2019 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434975 |
|
| 10/15/2019 |
Research |
Cash or cash equivalent |
|
$150.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434973 |
|
| 10/10/2019 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434971 |
|
| 10/10/2019 |
Research |
Cash or cash equivalent |
|
$90.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434969 |
|
| 10/10/2019 |
Research |
Cash or cash equivalent |
|
$1525.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434967 |
|
| 10/01/2019 |
Research |
Cash or cash equivalent |
|
$2000.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434965 |
|
| 09/17/2019 |
Research |
Cash or cash equivalent |
|
$11356.34 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434815 |
|
| 09/19/2019 |
Research |
Cash or cash equivalent |
|
$1000.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434813 |
|
| 09/26/2019 |
Research |
Cash or cash equivalent |
|
$640.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434811 |
|
| 09/24/2019 |
Research |
Cash or cash equivalent |
|
$90.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434809 |
|
| 09/24/2019 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434807 |
|
| 09/24/2019 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434805 |
|
| 08/29/2019 |
Research |
Cash or cash equivalent |
|
$8.13 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434585 |
|
| 08/29/2019 |
Research |
Cash or cash equivalent |
|
$300.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434583 |
|
| 08/20/2019 |
Research |
Cash or cash equivalent |
|
$9.34 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434581 |
|
| 08/20/2019 |
Research |
Cash or cash equivalent |
|
$13.66 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434579 |
|
| 08/20/2019 |
Research |
Cash or cash equivalent |
|
$8.90 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434577 |
|
| 08/20/2019 |
Research |
Cash or cash equivalent |
|
$5.86 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434575 |
|
| 08/20/2019 |
Research |
Cash or cash equivalent |
|
$34.84 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434573 |
|
| 08/20/2019 |
Research |
Cash or cash equivalent |
|
$25.24 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434571 |
|
| 08/20/2019 |
Research |
Cash or cash equivalent |
|
$40.80 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434569 |
|
| 08/20/2019 |
Research |
Cash or cash equivalent |
|
$17.91 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434567 |
|
| 08/05/2019 |
Research |
Cash or cash equivalent |
|
$463.20 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689434565 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$7.60 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433643 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$1.83 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433641 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$8.95 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433639 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$21.69 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433637 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$4.65 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433635 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433633 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$60.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433631 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433629 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$10.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433627 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$20.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433625 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$5.69 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433623 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$2.71 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433621 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433619 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$211.79 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433617 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$92.64 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433615 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$6.81 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433613 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$8.82 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433611 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$5.80 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433609 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$100.00 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433607 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$34.76 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433605 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$24.94 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433603 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$40.80 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433601 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$187.35 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433599 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$94.22 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433597 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$60.59 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433595 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$17.11 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433593 |
|
| 05/31/2019 |
Research |
Cash or cash equivalent |
|
$320.84 |
Details |
| Payment from |
Glenmark Pharmaceuticals Inc. |
| Paymment Research Study |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) |
| Payment Record ID |
689433591 |
|
| 05/15/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$35.45 |
Details |
| Payment from |
Galderma Laboratories, L.P. |
| Payment Record ID |
687662069 |
|
| 04/12/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$17.35 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
671969444 |
|
| 03/27/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$103.68 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
671930003 |
|
| 03/28/2019 |
General (Non-Research) |
Cash or cash equivalent |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$2625.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
671899049 |
|
| 03/21/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$120.11 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
671899047 |
|
| 03/22/2019 |
General (Non-Research) |
Cash or cash equivalent |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$2625.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
671898999 |
|
| 01/25/2019 |
General (Non-Research) |
Cash or cash equivalent |
Food and Beverage |
$21.65 |
Details |
| Payment from |
Biofrontera Inc. |
| Payment Record ID |
667996585 |
|
| 03/07/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$1.62 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
610739119 |
|
| 07/03/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$3.95 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
610529909 |
|
| 03/07/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$1.55 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
610514217 |
|
| 11/21/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$875.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
610383671 |
|
| 07/20/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$16.46 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
610358323 |
|
| 02/22/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$3.68 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
610314453 |
|
| 06/28/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$109.91 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
610309985 |
|
| 08/22/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$1.82 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
610303163 |
|
| 04/05/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$3.15 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
610291335 |
|
| 04/17/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$3.89 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
610286609 |
|
| 03/02/2018 |
General (Non-Research) |
Cash or cash equivalent |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$1500.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
609964561 |
|
| 07/02/2018 |
General (Non-Research) |
Cash or cash equivalent |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$1500.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
609964217 |
|
| 09/21/2018 |
General (Non-Research) |
Cash or cash equivalent |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$1500.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
609959787 |
|
| 09/20/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$81.11 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
609933067 |
|
| 03/01/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$109.62 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
609932095 |
|
| 11/14/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$3.37 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
609690901 |
|
| 12/04/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$4.23 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
609630189 |
|
| 04/27/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$24.98 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
594580277 |
|
| 05/09/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$102.31 |
Details |
| Payment from |
Lilly USA, LLC |
| Payment Record ID |
559179377 |
|
| 09/22/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$1.76 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
506744143 |
|
| 08/16/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$1.63 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
506743815 |
|
| 09/18/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$2.98 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
506743813 |
|
| 06/30/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$1.33 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
506743411 |
|
| 08/16/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$3.38 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
506743377 |
|
| 08/17/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$3.59 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
506743375 |
|
| 02/20/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$4.63 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
506380281 |
|
| 10/03/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$2.45 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
506376073 |
|
| 08/17/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1500.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
505935629 |
|
| 10/23/2017 |
General (Non-Research) |
Cash or cash equivalent |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$1500.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
505914685 |
|
| 11/29/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$109.89 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
505914683 |
|
| 10/19/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$104.52 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
505914619 |
|
| 12/07/2017 |
General (Non-Research) |
Cash or cash equivalent |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$1500.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
505914185 |
|
| 05/19/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.90 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
503111873 |
|
| 04/24/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.60 |
Details |
| Payment from |
Avion Pharmaceuticals |
| Payment Record ID |
502084479 |
|
| 04/20/2017 |
Research |
Cash or cash equivalent |
Drug |
$385.00 |
Details |
| Payment from |
TARO PHARMACEUTICALS USA, INC. |
| Paymment Research Study |
TaroAZAG 1533 |
| Payment Record ID |
501776051 |
|
| 02/20/2017 |
Research |
Cash or cash equivalent |
Drug |
$2025.00 |
Details |
| Payment from |
TARO PHARMACEUTICALS USA, INC. |
| Paymment Research Study |
TaroAZAG 1533 |
| Payment Record ID |
501776049 |
|
| 01/20/2017 |
Research |
Cash or cash equivalent |
Drug |
$1620.00 |
Details |
| Payment from |
TARO PHARMACEUTICALS USA, INC. |
| Paymment Research Study |
TaroAZAG 1533 |
| Payment Record ID |
501776047 |
|
| 04/20/2017 |
Research |
Cash or cash equivalent |
Drug |
$450.00 |
Details |
| Payment from |
TARO PHARMACEUTICALS USA, INC. |
| Paymment Research Study |
TaroAZAG 1533 |
| Payment Record ID |
501776045 |
|
| 01/03/2017 |
Research |
Cash or cash equivalent |
Drug |
$750.00 |
Details |
| Payment from |
TARO PHARMACEUTICALS USA, INC. |
| Paymment Research Study |
TaroAZAG 1533 |
| Payment Record ID |
501776037 |
|
| 06/10/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.46 |
Details |
| Payment from |
Mylan Pharmaceuticals Inc. |
| Payment Record ID |
490635323 |
|
| 03/31/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$20.62 |
Details |
| Payment from |
Celgene Corporation |
| Payment Record ID |
490094175 |
|
| 02/22/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$106.57 |
Details |
| Payment from |
AbbVie, Inc. |
| Payment Record ID |
472004495 |
|
| 01/20/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$6.55 |
Details |
| Payment from |
AbbVie, Inc. |
| Payment Record ID |
471794443 |
|
| 06/01/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$8.09 |
Details |
| Payment from |
AbbVie, Inc. |
| Payment Record ID |
471727919 |
|
| 04/27/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.06 |
Details |
| Payment from |
Galderma Laboratories, L.P. |
| Payment Record ID |
462407083 |
|
| 04/20/2017 |
General (Non-Research) |
Cash or cash equivalent |
Food and Beverage |
$10.81 |
Details |
| Payment from |
Aqua Pharmaceuticals |
| Payment Record ID |
458501726 |
|
| 04/20/2017 |
General (Non-Research) |
Cash or cash equivalent |
Food and Beverage |
$15.63 |
Details |
| Payment from |
Aqua Pharmaceuticals |
| Payment Record ID |
458501681 |
|
| 10/21/2016 |
General (Non-Research) |
Cash or cash equivalent |
Food and Beverage |
$15.44 |
Details |
| Payment from |
Encore Dermatology Inc. |
| Payment Record ID |
419011215 |
|
| 04/22/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.17 |
Details |
| Payment from |
Exeltis, USA Inc. |
| Payment Record ID |
415425727 |
|
| 02/19/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$84.42 |
Details |
| Payment from |
Pierre Fabre Pharmaceuticals, Inc. |
| Payment Record ID |
412290106 |
|
| 11/07/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$20.83 |
Details |
| Payment from |
Valeant Pharmaceuticals North America LLC |
| Payment Record ID |
410185268 |
|
| 02/23/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$14.68 |
Details |
| Payment from |
Valeant Pharmaceuticals North America LLC |
| Payment Record ID |
410185266 |
|
| 09/19/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$8.61 |
Details |
| Payment from |
AbbVie, Inc. |
| Payment Record ID |
408416290 |
|
| 06/21/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$68.49 |
Details |
| Payment from |
AbbVie, Inc. |
| Payment Record ID |
397491286 |
|
| 03/28/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$67.62 |
Details |
| Payment from |
AbbVie, Inc. |
| Payment Record ID |
397275382 |
|
| 05/31/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$8.75 |
Details |
| Payment from |
AbbVie, Inc. |
| Payment Record ID |
397140252 |
|
| 05/16/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.52 |
Details |
| Payment from |
AbbVie, Inc. |
| Payment Record ID |
396845966 |
|
| 10/06/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$96.37 |
Details |
| Payment from |
AbbVie, Inc. |
| Payment Record ID |
396163676 |
|
| 04/26/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.54 |
Details |
| Payment from |
AbbVie, Inc. |
| Payment Record ID |
396009784 |
|
| 04/02/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$104.45 |
Details |
| Payment from |
SANOFI-AVENTIS U.S. LLC |
| Payment Record ID |
393809330 |
|
| 09/21/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$18.19 |
Details |
| Payment from |
Medimetriks Pharmaceuticals, Inc. |
| Payment Record ID |
390638643 |
|
| 03/11/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$18.38 |
Details |
| Payment from |
Sandoz Inc. |
| Payment Record ID |
387583761 |
|
| 03/06/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$73.52 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
377260710 |
|
| 06/17/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$15.81 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
377260700 |
|
| 06/03/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$14.25 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
377260692 |
|
| 04/15/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.42 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
377260686 |
|
| 03/10/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$8.03 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
377260672 |
|
| 04/08/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$8.02 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
377260668 |
|
| 04/09/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$7.63 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
377260660 |
|
| 07/21/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$7.03 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
377260654 |
|
| 07/15/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$21.49 |
Details |
| Payment from |
Janssen Biotech, Inc. |
| Payment Record ID |
364991362 |
|
| 02/29/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.76 |
Details |
| Payment from |
Janssen Biotech, Inc. |
| Payment Record ID |
364802624 |
|
| 10/10/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$28.93 |
Details |
| Payment from |
Galderma Laboratories, L.P. |
| Payment Record ID |
362081224 |
|
| 08/26/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.91 |
Details |
| Payment from |
Galderma Laboratories, L.P. |
| Payment Record ID |
362081222 |
|
